1. Home
  2. SAMG vs ELDN Comparison

SAMG vs ELDN Comparison

Compare SAMG & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

N/A

Current Price

$14.75

Market Cap

125.5M

Sector

Finance

ML Signal

N/A

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

N/A

Current Price

$2.73

Market Cap

208.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SAMG
ELDN
Founded
2002
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.5M
208.6M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
SAMG
ELDN
Price
$14.75
$2.73
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
18.5K
900.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
5.64%
N/A
EPS Growth
N/A
54.27
EPS
0.55
N/A
Revenue
$91,358,000.00
N/A
Revenue This Year
$3.37
N/A
Revenue Next Year
$10.62
N/A
P/E Ratio
$27.09
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.23
$1.35
52 Week High
$17.01
$4.60

Technical Indicators

Market Signals
Indicator
SAMG
ELDN
Relative Strength Index (RSI) 39.74 59.49
Support Level $14.47 $2.48
Resistance Level $15.50 $2.77
Average True Range (ATR) 0.42 0.21
MACD -0.07 0.03
Stochastic Oscillator 31.61 56.22

Price Performance

Historical Comparison
SAMG
ELDN

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: